Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors
Open Access
- 12 July 2020
- Vol. 25 (14), 3180
- https://doi.org/10.3390/molecules25143180
Abstract
Chemical diversification of type II topoisomerase (Topo II) inhibitors remains indispensable to extend their anti-tumor therapeutic values which are limited by their side effects. Herein, we designed and synthesized a novel series of benzimidazole-chalcone hybrids (BCHs). These BCHs showed good inhibitory effect in the Topo II mediated DNA relaxation assay and anti-proliferative effect in 4 tumor cell lines. 4d and 4n were the most potent, with IC50 values less than 5 μM, superior to etoposide. Mechanistic studies indicated that the BCHs functioned as non-intercalative Topo II catalytic inhibitors. Moreover, 4d and 4n demonstrated versatile properties against tumors, including inhibition on the colony formation and cell migration, and promotion of apoptosis of A549 cells. The structure-activity relationship and molecular docking analysis suggested possible contribution of the chalcone motif to the Topo II inhibitory and anti-proliferative potency. These results indicated that 4d and 4n could be promising lead compounds for further anti-tumor drug research.Funding Information
- National Science Foundation of China (81502911)
This publication has 36 references indexed in Scilit:
- An Overview on CardamoninJournal of Medicinal Food, 2014
- Topoisomerase as target for antibacterial and anticancer drug discoveryJournal of Enzyme Inhibition and Medicinal Chemistry, 2012
- All tangled up: how cells direct, manage and exploit topoisomerase functionNature Reviews Molecular Cell Biology, 2011
- N-Fused Imidazoles As Novel Anticancer Agents That Inhibit Catalytic Activity of Topoisomerase IIα and Induce Apoptosis in G1/S PhaseJournal of Medicinal Chemistry, 2011
- Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moietyEuropean Journal of Medicinal Chemistry, 2010
- Second‐line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single‐center experienceAmerican Journal of Hematology, 2010
- In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivativesEuropean Journal of Medicinal Chemistry, 2010
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial DrugsCell Chemical Biology, 2010
- A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic ActivityJournal of Medicinal Chemistry, 2010
- Clonogenic assay of cells in vitroNature Protocols, 2006